Natural Products with Inhibitory Activity Against Human Immunodeficiency Virus Type 1
- Author: mycolabadmin
- 2021-05-29
- View Source
Summary
Background
HIV infection remains one of the main public health problems worldwide, with approximately 38 million people infected and 32% not receiving antiretroviral treatment. While antiretroviral therapy (ART) is effective at reducing viral load and increasing CD4+ T cell counts, issues with drug access, side effects, and viral resistance necessitate research into new therapeutic compounds. Natural products represent a promising source of anti-HIV compounds due to their therapeutic potential and potential for fewer side effects.
Objective
This review aimed to describe the wide repertoire of natural compounds exhibiting anti-HIV-1 activity that can be considered for designing new therapeutic strategies to curb the HIV pandemic. The review focused particularly on terpenes, coumarins, flavonoids, laccases, lectins, ribosome-inactivating proteins (RIPs), and bromotyrosines isolated from fungi, plants, and marine sponges.
Results
Conclusion
- Published in:Advances in Virology,
- Study Type:Review,
- Source: 10.1155/2021/5552088